David Colter, Ph.D
About David Colter, Ph.D
David Colter, Ph.D., is the Director of Analytical Development for the Cell Therapy Development Organization at Bristol Myers Squibb in Warren, New Jersey. He has extensive experience in biotherapeutics development and a strong background in biologics research.
Current Role at Bristol Myers Squibb
David Colter, Ph.D., is currently serving as the Director of Analytical Development at the Cell Therapy Development Organization of Bristol Myers Squibb. Located in Warren, New Jersey, he has held this position since September 2019. In this role, Colter leads the Analytical Development team, focusing on advancing cell therapy initiatives. His work is pivotal in developing new therapies and ensuring the analytical integrity of these therapies through rigorous methodologies.
Previous Positions at Janssen Pharmaceuticals
From 2015 to 2019, David Colter worked at The Janssen Pharmaceutical Companies of Johnson & Johnson as Associate Director of Biotherapeutics Development, specifically in Chemistry, Manufacturing, and Controls (CMC), located in Malvern, PA. Prior to this role, he served as Principal Scientist in Biologics Research at Janssen Inc. from 2012 to 2015. His work at Janssen spanned a diverse array of responsibilities, from overseeing biotherapeutics development to contributing significantly to the field of biologics research.
Experience at Johnson and Johnson
David Colter had a remarkable tenure at Johnson and Johnson, serving as Staff Scientist and Supervisor from 2005 to 2012. During this period, he was involved in Advanced Technologies and Regenerative Medicine, LLC at Johnson and Johnson. His responsibilities included supervising scientific staff and working on cutting-edge technologies aimed at regenerative medicine, highlighting his significant contributions to the advancement of medical technologies.
Academic Contributions as Adjunct Professor
David Colter contributed to the academic community as an Adjunct Professor at Holy Family University from 2004 to 2005. He taught in the Greater Philadelphia Area, sharing his expertise and knowledge in molecular and cell biology with students. This role underscores his commitment to education and his ability to mentor the next generation of scientists.
Educational Background and Postdoctoral Training
David Colter earned his B.S. in Biology from the University of Portland from 1992 to 1996. He then pursued a Ph.D. in Cell & Molecular Biology at Tulane University, completing it between 1999 and 2001. Following his Ph.D., Colter undertook postdoctoral training at Princeton University from 2003 to 2005, specializing in Molecular Biology and Hematology. His extensive academic training laid a strong foundation for his future career in biopharmaceuticals and cell therapy development.